Robert Weinstein

Robert Weinstein is an experienced financial executive who currently serves as the Chief Financial Officer (CFO) at Synaptogenix, Inc. Here are some key details about his background and career:

Current Roles

• CFO at Synaptogenix, Inc. (since 2013)2
• Director of Finance/CFO at Neurotrope, Inc. (since 2013)1
• Independent Director at several companies including XWELL, Inc., PharmaCyte Biotech, Inc., and Oblong, Inc.1

Professional Experience

Robert Weinstein has over 30 years of experience in accounting, finance, and executive leadership roles.3 Some of his previous positions include:

• CFO at Green Energy Management Services Holdings, Inc.3
• CFO at Xcorporeal, Inc.3
• Investment banker at Gruntal & Co. LLC1
• Founding partner in a healthcare-oriented private equity fund2
• Financial and accounting consultant to healthcare companies2

Education

• MBA in Finance and International Business from The University of Chicago Booth School of Business13
• BS in Accounting from the State University of New York at Albany13

Expertise

Weinstein has extensive experience in areas such as:

• Financial management and strategy
• SEC compliance and reporting
• Mergers and acquisitions
• Investor relations
• Healthcare and biotechnology industries

He is also a Certified Public Accountant (inactive).3

Compensation

As CFO of Synaptogenix, Weinstein's total compensation in 2020 was reported as $616,064, including a base salary of $397,500.4

Robert Weinstein has played a key role in Synaptogenix's financial operations and strategy since joining the company in 2013, helping to execute private financings and navigate the company's reverse merger.2